[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Transcatheter Heart Valve Therapies Market Growth 2024-2030

July 2024 | 96 pages | ID: G4D436347757EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Transcatheter heart valve therapies refer to minimally invasive procedures used to treat heart valve diseases, such as aortic stenosis or mitral regurgitation, without the need for open-heart surgery. During these procedures, a collapsible artificial valve is inserted into the heart via a catheter, typically through a blood vessel in the groin or chest. Once in position, the valve is expanded, replacing the damaged or diseased native valve and restoring proper blood flow. These innovative therapies offer significant advantages over traditional surgical approaches, including reduced recovery times, fewer complications, and improved outcomes for patients deemed high-risk or inoperable for conventional surgery.

The global Transcatheter Heart Valve Therapies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Transcatheter Heart Valve Therapies Industry Forecast” looks at past sales and reviews total world Transcatheter Heart Valve Therapies sales in 2023, providing a comprehensive analysis by region and market sector of projected Transcatheter Heart Valve Therapies sales for 2024 through 2030. With Transcatheter Heart Valve Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcatheter Heart Valve Therapies industry.

This Insight Report provides a comprehensive analysis of the global Transcatheter Heart Valve Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transcatheter Heart Valve Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcatheter Heart Valve Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcatheter Heart Valve Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcatheter Heart Valve Therapies.

United States market for Transcatheter Heart Valve Therapies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Transcatheter Heart Valve Therapies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Transcatheter Heart Valve Therapies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Transcatheter Heart Valve Therapies players cover Abbott, Edwards Lifesciences, Mitralign, Cardiac Dimensions, NeoChord, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Transcatheter Heart Valve Therapies market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Restorative Interventional Devices
  • Replacement Interventional Devices
Segmentation by Application:
  • Hospital
  • Clinic
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Abbott
  • Edwards Lifesciences
  • Mitralign
  • Cardiac Dimensions
  • NeoChord
  • Hanyu Medical
  • Valgen Medtech
Key Questions Addressed in this Report

What is the 10-year outlook for the global Transcatheter Heart Valve Therapies market?

What factors are driving Transcatheter Heart Valve Therapies market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Transcatheter Heart Valve Therapies market opportunities vary by end market size?

How does Transcatheter Heart Valve Therapies break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transcatheter Heart Valve Therapies Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Transcatheter Heart Valve Therapies by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Transcatheter Heart Valve Therapies by Country/Region, 2019, 2023 & 2030
2.2 Transcatheter Heart Valve Therapies Segment by Type
  2.2.1 Restorative Interventional Devices
  2.2.2 Replacement Interventional Devices
2.3 Transcatheter Heart Valve Therapies Sales by Type
  2.3.1 Global Transcatheter Heart Valve Therapies Sales Market Share by Type (2019-2024)
  2.3.2 Global Transcatheter Heart Valve Therapies Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Transcatheter Heart Valve Therapies Sale Price by Type (2019-2024)
2.4 Transcatheter Heart Valve Therapies Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
2.5 Transcatheter Heart Valve Therapies Sales by Application
  2.5.1 Global Transcatheter Heart Valve Therapies Sale Market Share by Application (2019-2024)
  2.5.2 Global Transcatheter Heart Valve Therapies Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Transcatheter Heart Valve Therapies Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Transcatheter Heart Valve Therapies Breakdown Data by Company
  3.1.1 Global Transcatheter Heart Valve Therapies Annual Sales by Company (2019-2024)
  3.1.2 Global Transcatheter Heart Valve Therapies Sales Market Share by Company (2019-2024)
3.2 Global Transcatheter Heart Valve Therapies Annual Revenue by Company (2019-2024)
  3.2.1 Global Transcatheter Heart Valve Therapies Revenue by Company (2019-2024)
  3.2.2 Global Transcatheter Heart Valve Therapies Revenue Market Share by Company (2019-2024)
3.3 Global Transcatheter Heart Valve Therapies Sale Price by Company
3.4 Key Manufacturers Transcatheter Heart Valve Therapies Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Transcatheter Heart Valve Therapies Product Location Distribution
  3.4.2 Players Transcatheter Heart Valve Therapies Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TRANSCATHETER HEART VALVE THERAPIES BY GEOGRAPHIC REGION

4.1 World Historic Transcatheter Heart Valve Therapies Market Size by Geographic Region (2019-2024)
  4.1.1 Global Transcatheter Heart Valve Therapies Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Transcatheter Heart Valve Therapies Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Transcatheter Heart Valve Therapies Market Size by Country/Region (2019-2024)
  4.2.1 Global Transcatheter Heart Valve Therapies Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Transcatheter Heart Valve Therapies Annual Revenue by Country/Region (2019-2024)
4.3 Americas Transcatheter Heart Valve Therapies Sales Growth
4.4 APAC Transcatheter Heart Valve Therapies Sales Growth
4.5 Europe Transcatheter Heart Valve Therapies Sales Growth
4.6 Middle East & Africa Transcatheter Heart Valve Therapies Sales Growth

5 AMERICAS

5.1 Americas Transcatheter Heart Valve Therapies Sales by Country
  5.1.1 Americas Transcatheter Heart Valve Therapies Sales by Country (2019-2024)
  5.1.2 Americas Transcatheter Heart Valve Therapies Revenue by Country (2019-2024)
5.2 Americas Transcatheter Heart Valve Therapies Sales by Type (2019-2024)
5.3 Americas Transcatheter Heart Valve Therapies Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Transcatheter Heart Valve Therapies Sales by Region
  6.1.1 APAC Transcatheter Heart Valve Therapies Sales by Region (2019-2024)
  6.1.2 APAC Transcatheter Heart Valve Therapies Revenue by Region (2019-2024)
6.2 APAC Transcatheter Heart Valve Therapies Sales by Type (2019-2024)
6.3 APAC Transcatheter Heart Valve Therapies Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Transcatheter Heart Valve Therapies by Country
  7.1.1 Europe Transcatheter Heart Valve Therapies Sales by Country (2019-2024)
  7.1.2 Europe Transcatheter Heart Valve Therapies Revenue by Country (2019-2024)
7.2 Europe Transcatheter Heart Valve Therapies Sales by Type (2019-2024)
7.3 Europe Transcatheter Heart Valve Therapies Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transcatheter Heart Valve Therapies by Country
  8.1.1 Middle East & Africa Transcatheter Heart Valve Therapies Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Transcatheter Heart Valve Therapies Revenue by Country (2019-2024)
8.2 Middle East & Africa Transcatheter Heart Valve Therapies Sales by Type (2019-2024)
8.3 Middle East & Africa Transcatheter Heart Valve Therapies Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transcatheter Heart Valve Therapies
10.3 Manufacturing Process Analysis of Transcatheter Heart Valve Therapies
10.4 Industry Chain Structure of Transcatheter Heart Valve Therapies

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Transcatheter Heart Valve Therapies Distributors
11.3 Transcatheter Heart Valve Therapies Customer

12 WORLD FORECAST REVIEW FOR TRANSCATHETER HEART VALVE THERAPIES BY GEOGRAPHIC REGION

12.1 Global Transcatheter Heart Valve Therapies Market Size Forecast by Region
  12.1.1 Global Transcatheter Heart Valve Therapies Forecast by Region (2025-2030)
  12.1.2 Global Transcatheter Heart Valve Therapies Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Transcatheter Heart Valve Therapies Forecast by Type (2025-2030)
12.7 Global Transcatheter Heart Valve Therapies Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Abbott
  13.1.1 Abbott Company Information
  13.1.2 Abbott Transcatheter Heart Valve Therapies Product Portfolios and Specifications
  13.1.3 Abbott Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Abbott Main Business Overview
  13.1.5 Abbott Latest Developments
13.2 Edwards Lifesciences
  13.2.1 Edwards Lifesciences Company Information
  13.2.2 Edwards Lifesciences Transcatheter Heart Valve Therapies Product Portfolios and Specifications
  13.2.3 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Edwards Lifesciences Main Business Overview
  13.2.5 Edwards Lifesciences Latest Developments
13.3 Mitralign
  13.3.1 Mitralign Company Information
  13.3.2 Mitralign Transcatheter Heart Valve Therapies Product Portfolios and Specifications
  13.3.3 Mitralign Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Mitralign Main Business Overview
  13.3.5 Mitralign Latest Developments
13.4 Cardiac Dimensions
  13.4.1 Cardiac Dimensions Company Information
  13.4.2 Cardiac Dimensions Transcatheter Heart Valve Therapies Product Portfolios and Specifications
  13.4.3 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Cardiac Dimensions Main Business Overview
  13.4.5 Cardiac Dimensions Latest Developments
13.5 NeoChord
  13.5.1 NeoChord Company Information
  13.5.2 NeoChord Transcatheter Heart Valve Therapies Product Portfolios and Specifications
  13.5.3 NeoChord Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 NeoChord Main Business Overview
  13.5.5 NeoChord Latest Developments
13.6 Hanyu Medical
  13.6.1 Hanyu Medical Company Information
  13.6.2 Hanyu Medical Transcatheter Heart Valve Therapies Product Portfolios and Specifications
  13.6.3 Hanyu Medical Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Hanyu Medical Main Business Overview
  13.6.5 Hanyu Medical Latest Developments
13.7 Valgen Medtech
  13.7.1 Valgen Medtech Company Information
  13.7.2 Valgen Medtech Transcatheter Heart Valve Therapies Product Portfolios and Specifications
  13.7.3 Valgen Medtech Transcatheter Heart Valve Therapies Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Valgen Medtech Main Business Overview
  13.7.5 Valgen Medtech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Transcatheter Heart Valve Therapies Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Transcatheter Heart Valve Therapies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Restorative Interventional Devices
Table 4. Major Players of Replacement Interventional Devices
Table 5. Global Transcatheter Heart Valve Therapies Sales by Type (2019-2024) & (Units)
Table 6. Global Transcatheter Heart Valve Therapies Sales Market Share by Type (2019-2024)
Table 7. Global Transcatheter Heart Valve Therapies Revenue by Type (2019-2024) & ($ million)
Table 8. Global Transcatheter Heart Valve Therapies Revenue Market Share by Type (2019-2024)
Table 9. Global Transcatheter Heart Valve Therapies Sale Price by Type (2019-2024) & (K US$/Unit)
Table 10. Global Transcatheter Heart Valve Therapies Sale by Application (2019-2024) & (Units)
Table 11. Global Transcatheter Heart Valve Therapies Sale Market Share by Application (2019-2024)
Table 12. Global Transcatheter Heart Valve Therapies Revenue by Application (2019-2024) & ($ million)
Table 13. Global Transcatheter Heart Valve Therapies Revenue Market Share by Application (2019-2024)
Table 14. Global Transcatheter Heart Valve Therapies Sale Price by Application (2019-2024) & (K US$/Unit)
Table 15. Global Transcatheter Heart Valve Therapies Sales by Company (2019-2024) & (Units)
Table 16. Global Transcatheter Heart Valve Therapies Sales Market Share by Company (2019-2024)
Table 17. Global Transcatheter Heart Valve Therapies Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Transcatheter Heart Valve Therapies Revenue Market Share by Company (2019-2024)
Table 19. Global Transcatheter Heart Valve Therapies Sale Price by Company (2019-2024) & (K US$/Unit)
Table 20. Key Manufacturers Transcatheter Heart Valve Therapies Producing Area Distribution and Sales Area
Table 21. Players Transcatheter Heart Valve Therapies Products Offered
Table 22. Transcatheter Heart Valve Therapies Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Transcatheter Heart Valve Therapies Sales by Geographic Region (2019-2024) & (Units)
Table 26. Global Transcatheter Heart Valve Therapies Sales Market Share Geographic Region (2019-2024)
Table 27. Global Transcatheter Heart Valve Therapies Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Transcatheter Heart Valve Therapies Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Transcatheter Heart Valve Therapies Sales by Country/Region (2019-2024) & (Units)
Table 30. Global Transcatheter Heart Valve Therapies Sales Market Share by Country/Region (2019-2024)
Table 31. Global Transcatheter Heart Valve Therapies Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Transcatheter Heart Valve Therapies Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Transcatheter Heart Valve Therapies Sales by Country (2019-2024) & (Units)
Table 34. Americas Transcatheter Heart Valve Therapies Sales Market Share by Country (2019-2024)
Table 35. Americas Transcatheter Heart Valve Therapies Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Transcatheter Heart Valve Therapies Sales by Type (2019-2024) & (Units)
Table 37. Americas Transcatheter Heart Valve Therapies Sales by Application (2019-2024) & (Units)
Table 38. APAC Transcatheter Heart Valve Therapies Sales by Region (2019-2024) & (Units)
Table 39. APAC Transcatheter Heart Valve Therapies Sales Market Share by Region (2019-2024)
Table 40. APAC Transcatheter Heart Valve Therapies Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Transcatheter Heart Valve Therapies Sales by Type (2019-2024) & (Units)
Table 42. APAC Transcatheter Heart Valve Therapies Sales by Application (2019-2024) & (Units)
Table 43. Europe Transcatheter Heart Valve Therapies Sales by Country (2019-2024) & (Units)
Table 44. Europe Transcatheter Heart Valve Therapies Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Transcatheter Heart Valve Therapies Sales by Type (2019-2024) & (Units)
Table 46. Europe Transcatheter Heart Valve Therapies Sales by Application (2019-2024) & (Units)
Table 47. Middle East & Africa Transcatheter Heart Valve Therapies Sales by Country (2019-2024) & (Units)
Table 48. Middle East & Africa Transcatheter Heart Valve Therapies Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Transcatheter Heart Valve Therapies Sales by Type (2019-2024) & (Units)
Table 50. Middle East & Africa Transcatheter Heart Valve Therapies Sales by Application (2019-2024) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Transcatheter Heart Valve Therapies
Table 52. Key Market Challenges & Risks of Transcatheter Heart Valve Therapies
Table 53. Key Industry Trends of Transcatheter Heart Valve Therapies
Table 54. Transcatheter Heart Valve Therapies Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Transcatheter Heart Valve Therapies Distributors List
Table 57. Transcatheter Heart Valve Therapies Customer List
Table 58. Global Transcatheter Heart Valve Therapies Sales Forecast by Region (2025-2030) & (Units)
Table 59. Global Transcatheter Heart Valve Therapies Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Transcatheter Heart Valve Therapies Sales Forecast by Country (2025-2030) & (Units)
Table 61. Americas Transcatheter Heart Valve Therapies Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Transcatheter Heart Valve Therapies Sales Forecast by Region (2025-2030) & (Units)
Table 63. APAC Transcatheter Heart Valve Therapies Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Transcatheter Heart Valve Therapies Sales Forecast by Country (2025-2030) & (Units)
Table 65. Europe Transcatheter Heart Valve Therapies Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Transcatheter Heart Valve Therapies Sales Forecast by Country (2025-2030) & (Units)
Table 67. Middle East & Africa Transcatheter Heart Valve Therapies Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Transcatheter Heart Valve Therapies Sales Forecast by Type (2025-2030) & (Units)
Table 69. Global Transcatheter Heart Valve Therapies Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Transcatheter Heart Valve Therapies Sales Forecast by Application (2025-2030) & (Units)
Table 71. Global Transcatheter Heart Valve Therapies Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Abbott Basic Information, Transcatheter Heart Valve Therapies Manufacturing Base, Sales Area and Its Competitors
Table 73. Abbott Transcatheter Heart Valve Therapies Product Portfolios and Specifications
Table 74. Abbott Transcatheter Heart Valve Therapies Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 75. Abbott Main Business
Table 76. Abbott Latest Developments
Table 77. Edwards Lifesciences Basic Information, Transcatheter Heart Valve Therapies Manufacturing Base, Sales Area and Its Competitors
Table 78. Edwards Lifesciences Transcatheter Heart Valve Therapies Product Portfolios and Specifications
Table 79. Edwards Lifesciences Transcatheter Heart Valve Therapies Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 80. Edwards Lifesciences Main Business
Table 81. Edwards Lifesciences Latest Developments
Table 82. Mitralign Basic Information, Transcatheter Heart Valve Therapies Manufacturing Base, Sales Area and Its Competitors
Table 83. Mitralign Transcatheter Heart Valve Therapies Product Portfolios and Specifications
Table 84. Mitralign Transcatheter Heart Valve Therapies Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 85. Mitralign Main Business
Table 86. Mitralign Latest Developments
Table 87. Cardiac Dimensions Basic Information, Transcatheter Heart Valve Therapies Manufacturing Base, Sales Area and Its Competitors
Table 88. Cardiac Dimensions Transcatheter Heart Valve Therapies Product Portfolios and Specifications
Table 89. Cardiac Dimensions Transcatheter Heart Valve Therapies Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 90. Cardiac Dimensions Main Business
Table 91. Cardiac Dimensions Latest Developments
Table 92. NeoChord Basic Information, Transcatheter Heart Valve Therapies Manufacturing Base, Sales Area and Its Competitors
Table 93. NeoChord Transcatheter Heart Valve Therapies Product Portfolios and Specifications
Table 94. NeoChord Transcatheter Heart Valve Therapies Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 95. NeoChord Main Business
Table 96. NeoChord Latest Developments
Table 97. Hanyu Medical Basic Information, Transcatheter Heart Valve Therapies Manufacturing Base, Sales Area and Its Competitors
Table 98. Hanyu Medical Transcatheter Heart Valve Therapies Product Portfolios and Specifications
Table 99. Hanyu Medical Transcatheter Heart Valve Therapies Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 100. Hanyu Medical Main Business
Table 101. Hanyu Medical Latest Developments
Table 102. Valgen Medtech Basic Information, Transcatheter Heart Valve Therapies Manufacturing Base, Sales Area and Its Competitors
Table 103. Valgen Medtech Transcatheter Heart Valve Therapies Product Portfolios and Specifications
Table 104. Valgen Medtech Transcatheter Heart Valve Therapies Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2019-2024)
Table 105. Valgen Medtech Main Business
Table 106. Valgen Medtech Latest Developments



LIST OF FIGURES

Figure 1. Picture of Transcatheter Heart Valve Therapies
Figure 2. Transcatheter Heart Valve Therapies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transcatheter Heart Valve Therapies Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Transcatheter Heart Valve Therapies Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Transcatheter Heart Valve Therapies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Transcatheter Heart Valve Therapies Sales Market Share by Country/Region (2023)
Figure 10. Transcatheter Heart Valve Therapies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Restorative Interventional Devices
Figure 12. Product Picture of Replacement Interventional Devices
Figure 13. Global Transcatheter Heart Valve Therapies Sales Market Share by Type in 2023
Figure 14. Global Transcatheter Heart Valve Therapies Revenue Market Share by Type (2019-2024)
Figure 15. Transcatheter Heart Valve Therapies Consumed in Hospital
Figure 16. Global Transcatheter Heart Valve Therapies Market: Hospital (2019-2024) & (Units)
Figure 17. Transcatheter Heart Valve Therapies Consumed in Clinic
Figure 18. Global Transcatheter Heart Valve Therapies Market: Clinic (2019-2024) & (Units)
Figure 19. Global Transcatheter Heart Valve Therapies Sale Market Share by Application (2023)
Figure 20. Global Transcatheter Heart Valve Therapies Revenue Market Share by Application in 2023
Figure 21. Transcatheter Heart Valve Therapies Sales by Company in 2023 (Units)
Figure 22. Global Transcatheter Heart Valve Therapies Sales Market Share by Company in 2023
Figure 23. Transcatheter Heart Valve Therapies Revenue by Company in 2023 ($ millions)
Figure 24. Global Transcatheter Heart Valve Therapies Revenue Market Share by Company in 2023
Figure 25. Global Transcatheter Heart Valve Therapies Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Transcatheter Heart Valve Therapies Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Transcatheter Heart Valve Therapies Sales 2019-2024 (Units)
Figure 28. Americas Transcatheter Heart Valve Therapies Revenue 2019-2024 ($ millions)
Figure 29. APAC Transcatheter Heart Valve Therapies Sales 2019-2024 (Units)
Figure 30. APAC Transcatheter Heart Valve Therapies Revenue 2019-2024 ($ millions)
Figure 31. Europe Transcatheter Heart Valve Therapies Sales 2019-2024 (Units)
Figure 32. Europe Transcatheter Heart Valve Therapies Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Transcatheter Heart Valve Therapies Sales 2019-2024 (Units)
Figure 34. Middle East & Africa Transcatheter Heart Valve Therapies Revenue 2019-2024 ($ millions)
Figure 35. Americas Transcatheter Heart Valve Therapies Sales Market Share by Country in 2023
Figure 36. Americas Transcatheter Heart Valve Therapies Revenue Market Share by Country (2019-2024)
Figure 37. Americas Transcatheter Heart Valve Therapies Sales Market Share by Type (2019-2024)
Figure 38. Americas Transcatheter Heart Valve Therapies Sales Market Share by Application (2019-2024)
Figure 39. United States Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Transcatheter Heart Valve Therapies Sales Market Share by Region in 2023
Figure 44. APAC Transcatheter Heart Valve Therapies Revenue Market Share by Region (2019-2024)
Figure 45. APAC Transcatheter Heart Valve Therapies Sales Market Share by Type (2019-2024)
Figure 46. APAC Transcatheter Heart Valve Therapies Sales Market Share by Application (2019-2024)
Figure 47. China Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 51. India Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Transcatheter Heart Valve Therapies Sales Market Share by Country in 2023
Figure 55. Europe Transcatheter Heart Valve Therapies Revenue Market Share by Country (2019-2024)
Figure 56. Europe Transcatheter Heart Valve Therapies Sales Market Share by Type (2019-2024)
Figure 57. Europe Transcatheter Heart Valve Therapies Sales Market Share by Application (2019-2024)
Figure 58. Germany Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 59. France Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Transcatheter Heart Valve Therapies Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Transcatheter Heart Valve Therapies Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Transcatheter Heart Valve Therapies Sales Market Share by Application (2019-2024)
Figure 66. Egypt Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Transcatheter Heart Valve Therapies Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Transcatheter Heart Valve Therapies in 2023
Figure 72. Manufacturing Process Analysis of Transcatheter Heart Valve Therapies
Figure 73. Industry Chain Structure of Transcatheter Heart Valve Therapies
Figure 74. Channels of Distribution
Figure 75. Global Transcatheter Heart Valve Therapies Sales Market Forecast by Region (2025-2030)
Figure 76. Global Transcatheter Heart Valve Therapies Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Transcatheter Heart Valve Therapies Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Transcatheter Heart Valve Therapies Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Transcatheter Heart Valve Therapies Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Transcatheter Heart Valve Therapies Revenue Market Share Forecast by Application (2025-2030)


More Publications